» Articles » PMID: 22422542

Relevance of the Primary Lesion in the Prognosis of Metastatic Cutaneous Squamous Cell Carcinoma

Overview
Journal Head Neck
Date 2012 Mar 17
PMID 22422542
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It remains unclear how primary tumor factors impact on prognosis in patients with nodal metastasis in head and neck cutaneous squamous cell carcinoma (SCC). The purpose of this study was to assess whether primary tumor characteristics are independent prognostic factors.

Methods: Patients treated for metastatic cutaneous SCC from 1978 to 2010 were identified (n = 239). A proportional hazards model was used to assess the effect of primary tumor variables.

Results: On multivariable analysis, tumor differentiation (hazard ratio [HR], 0.2; 95% confidence interval [CI], 0.1-0.8; p = .03) was found to be significantly associated with disease-specific survival (DSS), unlike margin status (p = .23), tumor size (p = .21), and thickness (p = .11). Patient, treatment, and nodal factors were confirmed to be important predictors of survival.

Conclusion: This article suggests that pathological features of the primary lesion bear little importance in the presence of established nodal metastasis, other than tumor differentiation. It validates the grouping of T1-3N1 as stage III under the current American Joint Committee on Cancer (AJCC) TNM staging system.

Citing Articles

Grading differentiation in cutaneous squamous cell carcinoma: a review of the literature.

Diede C, Walker T, Carr D, Shahwan K Arch Dermatol Res. 2024; 316(7):434.

PMID: 38935165 DOI: 10.1007/s00403-024-03184-w.


American Head and Neck Society position statement on the use of PD-1 inhibitors for treatment of advanced cutaneous squamous cell carcinoma.

Schmalbach C, Ow T, Choi K, OLeary M, Lin A, Hughley B Head Neck. 2022; 45(1):32-41.

PMID: 36181317 PMC: 11188044. DOI: 10.1002/hed.27202.


Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.

Farberg A, Fitzgerald A, Ibrahim S, Tolkachjov S, Soleymani T, Douglas L Dermatol Ther (Heidelb). 2022; 12(2):267-284.

PMID: 34994967 PMC: 8850485. DOI: 10.1007/s13555-021-00673-y.


Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review.

Brambullo T, Azzena G, Toninello P, Masciopinto G, De Lazzari A, Biffoli B Front Oncol. 2021; 11:783257.

PMID: 34950589 PMC: 8690035. DOI: 10.3389/fonc.2021.783257.


Cancer staging for rare cancers: should the American Joint Committee on Cancer have a separate staging classification for external auditory canal cancer?.

Clark J, Low H, Gupta R Ann Transl Med. 2019; 7(Suppl 1):S12.

PMID: 31032293 PMC: 6462635. DOI: 10.21037/atm.2019.01.33.